Evidence map›Paper›PMID 38228891›Full record

ArticleMolecular psychiatry2024

Deficiency of FRMD5 results in neurodevelopmental dysfunction and autistic-like behavior in mice.

Tian-Jie Lyu, Ji Ma, Xi-Yin Zhang, Guo-Guang Xie, Cheng Liu, Juan Du, Yi-Nuo Xu, De-Cao Yang, Cheng Cen, Meng-Yuan Wang and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Comprehensive characterization of the RNA editing landscape in the human aging brains with Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. An entropic explanation of insistence on sameness in autism.Frontiers in computational neuroscience · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tian-Jie Lyu *Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, National Health Commission and State Key Laboratory of Natural and Biomimetic Drugs, Peking University, 100191, Beijing, China.ORCID 0000-0002-1934-8643
Ji Ma *Department of Human Anatomy, Histology and Embryology, School of Basic Medical Sciences, State Key Laboratory of Molecular Oncology and International Cancer Institute, Peking University Health Science Center, 100191, Beijing, China.ORCID 0009-0008-4851-8876
Xi-Yin Zhang *Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, National Health Commission and State Key Laboratory of Natural and Biomimetic Drugs, Peking University, 100191, Beijing, China.ORCID 0009-0008-9325-9316
Guo-Guang Xie *Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, National Health Commission and State Key Laboratory of Natural and Biomimetic Drugs, Peking University, 100191, Beijing, China.ORCID 0009-0007-7049-7648
Cheng Liu *Department of Human Anatomy, Histology and Embryology, School of Basic Medical Sciences, State Key Laboratory of Molecular Oncology and International Cancer Institute, Peking University Health Science Center, 100191, Beijing, China.
Juan Du *Department of Human Anatomy, Histology and Embryology, School of Basic Medical Sciences, State Key Laboratory of Molecular Oncology and International Cancer Institute, Peking University Health Science Center, 100191, Beijing, China.ORCID 0000-0002-5675-3875
Yi-Nuo XuNeuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, National Health Commission and State Key Laboratory of Natural and Biomimetic Drugs, Peking University, 100191, Beijing, China.ORCID 0009-0009-7031-8587
De-Cao YangDepartment of Human Anatomy, Histology and Embryology, School of Basic Medical Sciences, State Key Laboratory of Molecular Oncology and International Cancer Institute, Peking University Health Science Center, 100191, Beijing, China.
Cheng CenNeuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, National Health Commission and State Key Laboratory of Natural and Biomimetic Drugs, Peking University, 100191, Beijing, China.ORCID 0000-0001-5364-0245
Meng-Yuan WangDepartment of Human Anatomy, Histology and Embryology, School of Basic Medical Sciences, State Key Laboratory of Molecular Oncology and International Cancer Institute, Peking University Health Science Center, 100191, Beijing, China.
Na-Yun LyuNeuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, National Health Commission and State Key Laboratory of Natural and Biomimetic Drugs, Peking University, 100191, Beijing, China.ORCID 0000-0001-6554-2036
Yun WangNeuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, National Health Commission and State Key Laboratory of Natural and Biomimetic Drugs, Peking University, 100191, Beijing, China. wangy66@bjmu.edu.cn.ORCID 0000-0002-4357-8166
Hong-Quan ZhangDepartment of Human Anatomy, Histology and Embryology, School of Basic Medical Sciences, State Key Laboratory of Molecular Oncology and International Cancer Institute, Peking University Health Science Center, 100191, Beijing, China. Hongquan.zhang@bjmu.edu.cn.ORCID 0000-0001-8193-0899

Funding

Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2017YFA0701302Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2021ZD0203204Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2022YFA1104003Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2022YFA1104003 and 2021YFC2501003National Natural Science Foundation of China (National Science Foundation of China) 81621063National Natural Science Foundation of China (National Science Foundation of China) 82230094National Natural Science Foundation of China (National Science Foundation of China) 82230094 and 81621063
6 · The paper itself

Abstract

The pathophysiology of autism spectrum disorders (ASDs) is causally linked to postsynaptic scaffolding proteins, as evidenced by numerous large-scale genomic studies [1, 2] and in vitro and in vivo neurobiological studies of mutations in animal models [3, 4]. However, due to the distinct phenotypic and genetic heterogeneity observed in ASD patients, individual mutation genes account for only a small proportion (<2%) of cases [1, 5]. Recently, a human genetic study revealed a correlation between de novo variants in FERM domain-containing-5 (FRMD5) and neurodevelopmental abnormalities [6]. In this study, we demonstrate that deficiency of the scaffolding protein FRMD5 leads to neurodevelopmental dysfunction and ASD-like behavior in mice. FRMD5 deficiency results in morphological abnormalities in neurons and synaptic dysfunction in mice. Frmd5-deficient mice display learning and memory dysfunction, impaired social function, and increased repetitive stereotyped behavior. Mechanistically, tandem mass tag (TMT)-labeled quantitative proteomics revealed that FRMD5 deletion affects the distribution of synaptic proteins involved in the pathological process of ASD. Collectively, our findings delineate the critical role of FRMD5 in neurodevelopment and ASD pathophysiology, suggesting potential therapeutic implications for the treatment of ASD.

Indexed as

Autism Spectrum DisorderDisease Models, AnimalMembrane ProteinsNeurodevelopmental DisordersAnimalsAutistic DisorderBehavior, AnimalCytoskeletal ProteinsFemaleMaleMiceMice, Inbred C57BLMice, KnockoutNeuronsSocial BehaviorStereotyped BehaviorCytoskeletal ProteinsMembrane Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.